KRX •
Healthcare •
Biotechnology •
Quote as of 10/30/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeKRX
Market Capitalization63,452,348 mln
Float12.36 mln
Earnings Date01/27/2027
EPS
30,285
Exceptional
P / E
49.10
High premium
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-3.13
Reliable
1-Year Forecast
1,879,148
Strong upside
Relative Strength
98
/ 100
Top performer
Business Description
Samsung Biologics, founded in 2011 and based in Incheon, South Korea, produces and delivers biopharmaceutical products to clients across South Korea, Europe, the United States, and other global markets. The company supports drug development from early research through to finished product, offering services such as cell line development, manufacturing, quality testing, and cold chain logistics. It also develops and manufactures specialized therapies including antibody-drug conjugates and mRNA-based products.
